NEW YORK (GenomeWeb) – PerkinElmer announced Tuesday it has signed an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission to create and implement a newborn screening training program focused on rural China.

Under the three-year agreement, PerkinElmer will provide its diagnostic tests and expertise to develop and roll out a program that will "substantially increase adoption and access to newborn screening in China," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.